Killing the Quality and Outcomes Framework won’t decrease prescribing for depressionBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2742 (Published 03 May 2013) Cite this as: BMJ 2013;346:f2742
- Tony Kendrick, professor of primary care1
- 1Hull York Medical School, University of York, York YO10 5DD, UK
Gillam and Steel imply that the Quality and Outcomes Framework (QOF) has contributed to increased prescribing of antidepressants.1 Where is the evidence? Prescriptions of selective serotonin reuptake inhibitors have risen steadily since their introduction in several countries,2 only one of which has a QOF.
We found that prescription increased due to small increments in the proportion of patients put on long term treatment over …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial